FiberChoice recall
This article was originally published in The Tan Sheet
Executive Summary
GlaxoSmithKline announces March 20 it is recalling 144,000 bottles of FiberChoice Plus Multivitamins because fish gelatin, a known allergen, was not declared on the label. The recall affects 90-count, 16 oz. bottles that began shipping to retailers Jan. 15. No reports of adverse reactions had been reported as of the recall announcement. The Food Allergen Labeling Consumer Protection Act of 2004 requires that manufacturers of dietary supplements disclose major food allergens on product labeling (1"The Tan Sheet" Oct. 24, 2005, p. 10). GSK completed its acquisition of FiberChoice manufacturer CNS in December 2006 (2"The Tan Sheet" Jan. 1, 2007, In Brief)...
You may also be interested in...
FDA Guidance Clarifies Labeling For Supplements Containing Food Allergens
Manufacturers of dietary supplements are required to begin labeling products that contain major food allergens on Jan. 1 in order to comply with the Food Allergen Labeling & Consumer Protection Act of 2004 (FALCPA)
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.